{{Rsnum
|rsid=6427356
|Chromosome=1
|position=157160775
|Orientation=plus
|GMAF=0.4793
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 55.4 | 36.9 | 7.7
| HCB | 0.0 | 11.4 | 88.6
| JPT | 0.0 | 24.4 | 75.6
| YRI | 49.2 | 36.5 | 14.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 11.4 | 88.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18951430
|Trait=Attention-deficit/hyperactivity disorder and conduct disorder
|Title=Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study
|RiskAllele=G
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs6427356
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18951430; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. (Initial Sample Size: 938 affected trios; Replication Sample Size: NR); (Region: 1q23.1; Reported Gene(s): ETV3L, ETV3; Risk Allele: rs6427356-G); (p-value= 0.000008).This variant is associated with Attention-deficit/hyperactivity disorder and conduct disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740781
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6427356
|overall_frequency_n=56
|overall_frequency_d=128
|overall_frequency=0.4375
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=47
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}